The Transpara tool has been clinically proven to ... of Transpara to improve performance for mammography-based breast cancer risk assessment. This is a game-changing step in providing accurate ...

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result ...

Gastounioti The National Cancer Institute, part of the National Institutes of Health (NIH), has awarded Aimilia Gastounioti a ...

To better tailor screening decisions for women 40-49 years old, Kerlikowske uses the Breast Cancer Surveillance Consortium ...

Hall shared her story on "CBS Mornings," explaining how Munn's advocacy for early detection, along with a breast cancer risk assessment tool, led to her life-saving diagnosis. Munn credited the ...

A recent study suggests that a simple blood test measuring epigenetic aging could help predict breast cancer risk in older ...

Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.

The researchers completed a comprehensive functional assessment of all ... a clearer picture of cancer risk and tailor both prevention strategies as well as breast cancer treatment accordingly." ...

Winnipeg-born reporter Alison Hall was diagnosed with breast cancer after covering actress Olivia Munn’s diagnosis. Hall, 33, ...

“These findings further support Myriad’s commitment to provider ease of use and patient access by enabling an always-on tool to drive appropriate patient identification and education, via our Breast ...

Netherlands-based ScreenPoint Medical has acquired Biomediq A/S, the Danish developer of mammogram analysis technology, to advance the capabilities of its AI-powered Transpara: Breast AI screening ...